Metformin therapy in women with polycystic ovary syndrome

International Journal of Gynecology and Obstetrics

Volumn 87, Issue 3, 2004, Pages 237-241

  Aruna, J ^a   Mittal, S ^a   Kumar, S ^a   Misra, R ^a   Dadhwal, V ^a   Vimala, N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Hyperandrogenism; Hyperinsulinemia; Metformin; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; GLUCOSE; GLYCIPHAGE; GONADOTROPIN; INSULIN; LUTEINIZING HORMONE; METFORMIN; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ACNE; ADOLESCENT; ADULT; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ECHOGRAPHY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HIRSUTISM; HUMAN; INFERTILITY; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; MORPHOMETRICS; ORAL GLUCOSE TOLERANCE TEST; OVARY; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; OVULATION; PREGNANCY RATE; PREMEDICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL;

EID: 8844279990     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2004.08.015     Document Type: Article

References (17)

1. J.W. Goldzieher, and J.A. Green The polycystic ovary: clinical and histopathological features J. Clin. Endocrinol. Metab. 22 1962 325 328
2. R.L. Barbieri, S. Smith, and K.J. Ryan The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism Fertil. Steril. 50 1988 197 212
3. A. Dunaif, K.R. Segal, D.R. Shelley, G. Green, and A. Dorbrjansky Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome Diabetes 38 1989 1165 1174
4. C.B. Coulam, J.F. Annegers, and J.S. Kranz Chronic anovulation syndrome and associated neoplasia Obstet. Gynecol. 61 1983 403 407
5. C.J. Bailey, and R.C. Turner Metformin N. Engl. J. Med. 334 1996 574 579
6. J. Adams, D.W. Polson, and S. Franks Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism Br. Med. J. 293 1986 355 359
7. The Rotterdam ESHRE/ASRM-Revised 2003 Consensus on diagnostic criteria and long term health risks related to PCOS Hum. Reprod. 19 2004 41 47
8. C.N. Wijeyaratne, A.H. Balen, J.H. Barth, and P.E. Belchetz Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin. Endocrinol. 57 2002 343 350
9. E.M. Velazquez, S. Mendoza, T. Hamer, F. Sosa, and C.J. Glueck Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia and systolic blood pressure while facilitating normal menses and pregnancy Metab. Clin. Exp. 43 1994 647 654
10. L.C. Morin-Papunen, R.M. Koivunen, A. Ruokonen, and H.K. Martikainen Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome Fertil. Steril. 69 1998 691 696
11. E.S. Knochenhauer, T.J. Key, M. Kahasar-Miller, W. Waggunen, and L.R. Boots Prevalence of polycystic ovary syndrome in unselected black and white women of south eastern United States: a prospective study J. Clin. Endocrinol. Metab. 83 1998 3078 3082
12. O. Acbay, and S. Gundogdu Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil. Steril. 65 1996 946 949
13. D.T. Vandermolen, V.S. Ratts, and W.S. Evans Metformin increases the ovulatory rate and pregnancy rate with clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone Fertil. Steril. 75 2001 310 315
14. P. Moghetti, R. Castello, C. Negri, F. Tosi, F. Perrone, and M. Caputo Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome. A randomised, double- blind, placebo-controlled 6 month trial, followed by open, long term clinical evaluation J. Clin. Endocrinol. Metab. 85 2000 139 146
15. R. Fleming, Z.E. Hopkinson, A.M. Wallace, I.A. Greer, and N. Sattar Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomised double blind placebo controlled trial J. Clin. Endocrinol. Metab. 87 2002 569 574
16. W.F. Sample, B.M. Lippe, and M.T. Gyepes Grayscale ultrasonography of the normal female pelvis Radiology 125 1977 477 483
17. American Diabetes Association Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 20 1997 1183 1197